Forsta AP Fonden Boosts Holdings in Zoetis Inc. $ZTS

Forsta AP Fonden boosted its position in shares of Zoetis Inc. (NYSE:ZTS) by 23.1% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 183,100 shares of the company’s stock after purchasing an additional 34,300 shares during the period. Forsta AP Fonden’s holdings in Zoetis were worth $28,554,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of ZTS. KBC Group NV grew its holdings in shares of Zoetis by 7.8% during the second quarter. KBC Group NV now owns 340,527 shares of the company’s stock valued at $53,105,000 after buying an additional 24,704 shares during the last quarter. Jupiter Asset Management Ltd. lifted its position in Zoetis by 2,954.9% in the 2nd quarter. Jupiter Asset Management Ltd. now owns 422,743 shares of the company’s stock valued at $65,927,000 after acquiring an additional 408,905 shares in the last quarter. Ironwood Investment Counsel LLC boosted its stake in Zoetis by 1.5% during the 2nd quarter. Ironwood Investment Counsel LLC now owns 5,537 shares of the company’s stock valued at $864,000 after purchasing an additional 80 shares during the last quarter. National Pension Service increased its holdings in shares of Zoetis by 4.0% in the 2nd quarter. National Pension Service now owns 1,371,358 shares of the company’s stock worth $213,863,000 after purchasing an additional 52,376 shares in the last quarter. Finally, Advyzon Investment Management LLC purchased a new position in shares of Zoetis in the second quarter worth $215,000. 92.80% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Zoetis in a research report on Wednesday, October 8th. Morgan Stanley dropped their price target on shares of Zoetis from $211.00 to $175.00 and set an “overweight” rating on the stock in a report on Monday. UBS Group reduced their price target on shares of Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. JPMorgan Chase & Co. lowered their price objective on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 5th. Finally, Argus reaffirmed a “buy” rating and issued a $190.00 target price on shares of Zoetis in a research report on Tuesday, September 9th. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, Zoetis presently has an average rating of “Moderate Buy” and a consensus target price of $182.50.

Zoetis Trading Up 0.3%

Shares of Zoetis stock opened at $120.09 on Wednesday. Zoetis Inc. has a 1-year low of $117.26 and a 1-year high of $181.85. The company’s fifty day simple moving average is $142.82 and its 200-day simple moving average is $152.16. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. The stock has a market capitalization of $52.92 billion, a PE ratio of 20.67, a P/E/G ratio of 2.31 and a beta of 0.90.

Zoetis (NYSE:ZTS) last announced its earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. The company had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.42 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.Zoetis’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period last year, the firm earned $1.58 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis’s payout ratio is presently 33.67%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.